Completed OBSERVATIONAL NCT00994721

A Phase III Study of Pancreatic Cancer

A Randomized Phase III Study of Adjuvant Gemcitabine Versus Gemcitabine Plus Concurrent Chemoradiation in Pancreatic Cancer Underwent Curative Intent (R0 / R1) Resection

Sponsor: Chang Gung Memorial Hospital

Conditions Pancreatic Cancer

Updated 6 times since 2017 Last updated: May 3, 2016 Started: Feb 28, 2009 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00994721, this observational or N/A phase trial focuses on Pancreatic Cancer and remains completed. Sponsored by Chang Gung Memorial Hospital, it has been updated 6 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE3 → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed PHASE3

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chang Gung Memorial Hospital
Kaohsiung Medical University
Kaohsiung Veterans General Hospital.
Mackay Memorial Hospital
National Cheng-Kung University Hospital
National Health Research Institutes, Taiwan
National Taiwan University Hospital
Taichung Veterans General Hospital
Taipei Veterans General Hospital, Taiwan

Data source: National Health Research Institutes, Taiwan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan